Provan, S. A., Berg, I. J., Hammer, H. B., Mathiessen, A., Kvien, T. K., & Semb, A. G. (2015). The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab. PLoS One.

Provan, Sella Aarrestad, Inger Jorid Berg, Hilde Berner Hammer, Alexander Mathiessen, Tore Kristian Kvien, e Anne Grete Semb. "The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs On Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated With Rituximab, Abatacept and Tociliziumab." PLoS One 2015.

Provan, Sella Aarrestad, et al. "The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs On Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated With Rituximab, Abatacept and Tociliziumab." PLoS One 2015.